{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:29:46Z","timestamp":1762205386346,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100003482","name":"John Wayne Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003482","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jim.2021.113157","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T12:19:28Z","timestamp":1632831568000},"page":"113157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Preparation of clinical-grade WBCs using leukocyte reduction filters"],"prefix":"10.1016","volume":"499","author":[{"given":"Girja S.","family":"Shukla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie C.","family":"Pero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Hitchcox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Krag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2021.113157_bb0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-1759(01)00337-4","article-title":"Generation of large numbers of human dendritic cells from whole blood passaged through leukocyte removal filters: an alternative to standard buffy coats","volume":"252","author":"Ebner","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2021.113157_bb0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00002371-199705000-00007","article-title":"Points to consider in the manufacture and testing of monoclonal antibody products for human use (1997). U.S. Food and Drug Administration Center for Biologics Evaluation and Research","volume":"20","author":"FDA, U.S","year":"1997","journal-title":"J. Immunother."},{"key":"10.1016\/j.jim.2021.113157_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tracli.2019.11.001","article-title":"Characterization of peripheral blood mononuclear cells isolated using two kinds of leukocyte filters","volume":"27","author":"He","year":"2020","journal-title":"Transfus. Clin. Biol."},{"key":"10.1016\/j.jim.2021.113157_bb0020","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4049\/jimmunol.125.2.926","article-title":"Antibody-dependent cell-mediated cytolysis (ADCC) with antibody-coated effectors: new methods for enhancing antibody binding and cytolysis","volume":"125","author":"Jones","year":"1980","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2021.113157_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jim.2005.10.004","article-title":"Filter Buffy coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters","volume":"307","author":"Meyer","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2021.113157_bb0030","first-page":"839","article-title":"Apparent direct cellular cytotoxicity mediated via cytophilic antibody. Multiple Fc receptor bearing effector cell populations mediating cytophilic antibody induced cytotoxicity","volume":"33","author":"Parrillo","year":"1977","journal-title":"Immunology"},{"key":"10.1016\/j.jim.2021.113157_bb0035","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1537-2995.2010.02683.x","article-title":"Obtaining of CD34+ cells from healthy blood donors: development of a rapid and efficient procedure using leukoreduction filters","volume":"50","author":"Peytour","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.jim.2021.113157_bb0040","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s12094-019-02235-3","article-title":"Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models","volume":"22","author":"Shukla","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jim.2021.113157_bb0045","doi-asserted-by":"crossref","first-page":"112720","DOI":"10.1016\/j.jim.2019.112720","article-title":"A cocktail of polyclonal affinity enriched antibodies against melanoma mutations increases binding and inhibits tumor growth","volume":"478","author":"Shukla","year":"2020","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2021.113157_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biologicals.2017.07.006","article-title":"Recovery and assessment of leukocytes from LR express filters","volume":"49","author":"Wegehaupt","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.jim.2021.113157_bb0055","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1537-2995.2011.03238.x","article-title":"Peripheral blood mononuclear cells obtained from leukoreduction system chambers show better viability than those from leukapheresis","volume":"51","author":"Weidinger","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.jim.2021.113157_bb0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2144\/01313bm01","article-title":"Blood donor leukocyte reduction filters as a source of human B lymphocytes","volume":"31","author":"Weitkamp","year":"2001","journal-title":"BioTechniques"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921002027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921002027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:28:00Z","timestamp":1762205280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175921002027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":12,"alternative-id":["S0022175921002027"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2021.113157","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation of clinical-grade WBCs using leukocyte reduction filters","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2021.113157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113157"}}